Teachers Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Teachers Advisors’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,961	Closed	-$207K	–	3195
2016 Q1	$207K	Hold	10,961	–	–	﹤0.01%	2785
2015 Q4	$292K	Hold	10,961	–	–	﹤0.01%	2722
2015 Q3	$500K	Hold	10,961	–	–	﹤0.01%	2397
2015 Q2	$353K	Buy	10,961 +633	+6%	+$18.4K	﹤0.01%	2737
2015 Q1	$328K	Hold	10,328	–	–	﹤0.01%	2673
2014 Q4	$390K	Hold	10,328	–	–	﹤0.01%	2573
2014 Q3	$273K	Hold	10,328	–	–	﹤0.01%	2733
2014 Q2	$306K	Buy	10,328 +1,345	+15%	+$43.5K	﹤0.01%	2726
2014 Q1	$332K	Buy	8,983 +1,163	+15%	+$44.1K	﹤0.01%	2622
2013 Q4	$324K	Hold	7,820	–	–	﹤0.01%	2617
2013 Q3	$414K	Buy	7,820 +433	+6%	+$25.2K	﹤0.01%	2442
2013 Q2	$394K	Buy	+7,387	New	+$369K	﹤0.01%	2370

Other funds holding NAVB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Teachers Advisors's NAVB Position: Q2 2016 in Review

Teachers Advisors sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2016, closing a stake of 10,961 shares — an estimated $207K sold.

Teachers Advisors first reported a position in NAVB in Q2 2013 and held it in 12 quarters. The position peaked at $500K in Q3 2015. 63 funds tracked by Wall St. Rank hold NAVB as of Q2 2016.

Teachers Advisors reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
Teachers Advisors sold 10,961 Navidea Biopharmaceuticals Inc. shares in Q2 2016, an estimated $207K.
Teachers Advisors first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 12 quarters.
Teachers Advisors's Navidea Biopharmaceuticals Inc. position peaked at $500K in Q3 2015.
63 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2016.

Based on Teachers Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.